Section Arrow
SANA.NASDAQ
- Sana Biotechnology
Quotes are at least 15-min delayed:2024/06/24 08:23 EDT
Last
 5.505
+0.275 (+5.26%)
Day High 
5.55 
Prev. Close
5.23 
1-M High
8.7 
Volume 
3.23M 
Bid
5.6
Ask
6.9
Day Low
5.234 
Open
5.25 
1-M Low
5.2 
Market Cap 
1.16B 
Currency USD 
P/E -- 
%Yield
10-SMA 6.51 
20-SMA 7.16 
50-SMA 8.11 
52-W High 12 
52-W Low 2.745 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
-1.52/-1.05
Enterprise Value
1.25B
Balance Sheet
Book Value Per Share
1.69
Cash Flow
Cash Flow Yield
--
Income Statement
Total Revenue
0
Operating Revenue Per Share
--
Industry Comparison
Code Name   Last Change Change (%) P/E P/E Range
MBIOMustang Bio0.5594-0.0011-0.20%-- 
DNAGinkgo Bioworks Holdings0.4244+0.0157+3.84%-- 
KTRAKintara Therapeutics0.2472-0.0277-10.08%-- 
BMRNBioMarin Pharmaceutical83.72-0.99-1.17%79.92PE
QLGNQualigen Therapeutics0.222+0.0449+25.35%-- 
Quotes are at least 15-min delayed:2024/06/24 08:23 EDT
Industry overview quotes are at least 15 minutes delayed
Business Description
Sana Biotechnology Inc is a biotechnology company. The company develops engineered cells as medicines and therapies to treat diseases. It is engaged in developing cell engineering programs for across a broad array of therapeutic areas withunmet treatment needs, including oncology, diabetes, B-cell-mediated autoimmune, and central nervous system (CNS) disorders, among others. Its pipeline of product candidates is comprised of SC291, SC262, SC255, UP421 among others.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.